TLSI
TriSalus Life Sciences, Inc. - Common Stock (TLSI)
$75
About TriSalus Life Sciences, Inc. - Common Stock (TLSI)
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.
Details
Daily high
$4.75
Daily low
$4.62
Price at open
$4.67
52 Week High
$6.04
52 Week Low
$3.50
Market cap
180.0M
Dividend yield
0.00%
Volume
14,319
Avg. volume
167,683
P/E ratio
-4.23
TriSalus Life Sciences, Inc. - Common Stock News
Details
Daily high
$4.75
Daily low
$4.62
Price at open
$4.67
52 Week High
$6.04
52 Week Low
$3.50
Market cap
180.0M
Dividend yield
0.00%
Volume
14,319
Avg. volume
167,683
P/E ratio
-4.23